(a) whether a large number of companies are marketing Atorvastatin
and Asprin combinations without price approval;
(b) if so, whether the National Pharmaceutical Pricing Authority
(NPPA) has served notices of overcharging to these companies;
(c) if so, the details thereof;
(d) the names of the companies to which the notices have been served; and
(e) the names of the products and the amount overcharged alongwith the amount
likely to be recovered from these companies?
MINISTER OF THE STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI SRIKANT KUMAR JENA)
(a) to (e): The National Pharmaceutical Pricing Authority (NPPA) has sent notices to the following companies,
as per details mentioned against each, where they have been found to be marketing Atorvastatin + Aspirin
combinations formulations over and above the ceiling price notified by NPPA:-
s. Name of the Product Amount Amount No. Company name demanded recovered (Rs. in Lakhs) (Rs. in Lakhs)
1 Swiss Gamier Tonact - 226.9 42.69 Lifesciences ASP 75 Ltd. / Lupin Ltd.
2 Sidmak Laboratories ASP Atorva 64.97 India Pvt. Ltd.
3 Tristar Formulation Ecosptn AV 518.15 125.00 Pvt. Ltd.